Eletriptan
Back to searchMolecule Structure
Scientific Name
Eletriptan
Description of the Drug
Eletriptan is a triptan used for the treatment of migraines.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00216
http://www.drugbank.ca/drugs/DB00216
Brand Name(s)
Relpax
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Teva Pharmaceuticals Usa Inc, Ajanta Pharma Ltd, Upjohn Manufacturing Ireland Unltd, Yung Shin Pharmaceutical Industrial Co Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Beximco Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 1f (5-HT1f) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1805 |
Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Serotonin 1b (5-HT1b) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1898 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL26719 | ||
PharmGKB | PA134687947 | ||
Human Metabolome Database | HMDB0014361 | ||
DrugBank | DB00216 | ||
PubChem: Thomson Pharma | 14927226 | 14829466 | |
PubChem | 77993 | ||
Nikkaji | J979.643F | ||
BindingDB | 50103594 | ||
EPA CompTox Dashboard | DTXSID9046861 | ||
DrugCentral | 995 | ||
ChemicalBook | CB1404591 | ||
Guide to Pharmacology | 40 | ||
rxnorm | ELETRIPTAN | ELETRIPTAN HYDROBROMIDE | RELPAX |
PubChem: Drugs of the Future | 12014973 | ||
ChEBI | 50922 | ||
ZINC | ZINC000003823475 |